TAMPA, Fla., March 29, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today announced ...
— EXPAREL is the only FDA-approved single-dose regional analgesic to safely demonstrate four days of superiority versus bupivacaine in two clinical studies — — New indications for use as an adductor ...
The Food and Drug Administration (FDA) has approved the use of Exparel (bupivacaine liposome injectable suspension; Pacira Pharmaceuticals) as an interscalene brachial plexus block to produce ...
In summary, the present study shows that ropivacaine 50 mg given around interscalene brachial plexus as 0.25, 0.5 or 0.75 % solution before arthroscopic shoulder surgery produces comparable blockade ...
In both studies, Exparel achieved a statistically significant reduction in cumulative pain scores from 0 to 96 hours compared with bupivacaine hydrochloride. The Food and Drug Administration (FDA) has ...
Please provide your email address to receive an email when new articles are posted on . Use of liposomal bupivacaine in an interscalene nerve block effectively controlled pain after outpatient ...
Patients who received interscalene brachial plexus block plus soft tissue infiltration with Exparel when undergoing primary shoulder arthroplasty used significantly more narcotics postoperatively and ...
Ultrasound-guided nerve blocks for preoperative pain management after hip fracture provide improvements over conventional anesthesia including greater pain reduction and fewer adverse events, results ...
DUBAI, United Arab Emirates--(BUSINESS WIRE)--Prime Hospital, one of the UAE's leading healthcare service providers, has achieved another milestone by applying various innovative Anesthetic Techniques ...
A nerve block works by preventing pain signals from reaching the brain. There are permanent and temporary options. Both are generally safe procedures. Nerve blocks are an effective way to prevent, ...